Fulgent Genetics, Inc.FLGTNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank18
3Y CAGR-18.7%
5Y CAGR-33.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-18.7%/yr
vs -11.1%/yr prior
5Y CAGR
-33.0%/yr
Recent acceleration
Acceleration
-7.5pp
Decelerating
Percentile
P18
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 10.42% |
| 2024 | 17.80% |
| 2023 | 43.34% |
| 2022 | 19.37% |
| 2021 | 109.15% |
| 2020 | 77.15% |
| 2019 | 18.12% |
| 2018 | 31.04% |
| 2017 | 18.69% |
| 2016 | -19.70% |